Press ReleasesRecent Press ReleasesFor information regarding press releases please contact us at:
Phone: (402) 452-5437
Fax: (402) 452-5461
E-mail: investorrelations@transgenomic.com DisclaimerThe following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date. Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements. Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based. Recent Releases| February 8, 2010 | View | Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples using COLD-PCR | | | | February 5, 2010 | View | Transgenomic Presents at 12th Annual BIO CEO & Investor Conference | | | | December 17, 2009 | View | Transgenomic, Inc. Executes License Option Agreement for Parkinson’s Disease Diagnostic Markers with Gene Solutions, LLC | | | | December 8, 2009 | View | Transgenomic Announces the Commercial Launch of SURVEYOR® Scan K-RAS Mutation Detection Kit | | | | November 5, 2009 | View | Transgenomic, Inc. Reports Third Quarter 2009 Results | | |
|